| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/06/2000 | WO2000018385A2 Use of acylcarnitines as antitumour agents |
| 04/06/2000 | WO2000018352A2 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | WO2000018351A2 Aglyco products and methods of use |
| 04/06/2000 | WO2000018233A1 Synthetic analogs of ecteinascidin-743 |
| 04/06/2000 | WO2000018230A1 Combination of bisphosphonate and tetracycline |
| 04/06/2000 | WO2000018212A2 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
| 04/06/2000 | WO2000006588B1 STEREOISOMERS OF CpG OLIGONUCLEOTIDES AND RELATED METHODS |
| 04/06/2000 | WO1999067384A3 Prostate cancer-associated genes |
| 04/06/2000 | WO1999064596A3 Proteins regulating gene expression |
| 04/06/2000 | WO1999062944A3 Protein oligomer compositions comprising endostatin protein and methods of using the same |
| 04/06/2000 | WO1999062941A3 Serpentine transmembrane antigens expressed in human cancers and uses thereof |
| 04/06/2000 | WO1999061610A3 TUMOUR SUPPRESSOR GENES OF THE p53 FAMILY |
| 04/06/2000 | WO1999061057A3 Molecules targeting cd40 and tumor cells |
| 04/06/2000 | WO1999061056A3 Methods and products for inducing mucosal immunity |
| 04/06/2000 | WO1999058162A3 Pharmaceuticals for the imaging of angiogenic disorders |
| 04/06/2000 | WO1999057144A3 Human transcriptional regulator molecules |
| 04/06/2000 | WO1999046284A3 Molecules that home to various selected organs or tissues |
| 04/06/2000 | CA2368856A1 Immunotherapy of cancer through expression of truncated tumor or tumor-associated antigen |
| 04/06/2000 | CA2345988A1 Compounds for the treatment of estrogen-dependent illnesses and methods for making and using the same |
| 04/06/2000 | CA2345641A1 A method for treating inflammatory diseases by administering a thrombin inhibitor |
| 04/06/2000 | CA2345474A1 Oxazole compounds as prostaglandin e2 agonists or antagonists |
| 04/06/2000 | CA2345357A1 Benzimidazolinyl piperidines as cgrp ligands |
| 04/06/2000 | CA2345273A1 Pharmaceutically active compounds and methods of use thereof |
| 04/06/2000 | CA2344766A1 Antibodies to mammalian langerhans cell antigen and their uses |
| 04/06/2000 | CA2344712A1 Secretory protein- zsig48 |
| 04/06/2000 | CA2344658A1 Human kinesin-like motor protein |
| 04/06/2000 | CA2344653A1 Methods of controlling proliferation and differentiation of stem and progenitor cells |
| 04/06/2000 | CA2344561A1 Platelet-derived growth factor c, dna coding therefor, and uses thereof |
| 04/06/2000 | CA2344550A1 Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer |
| 04/06/2000 | CA2343972A1 Ykl-40 as a marker and prognostic indicator for cancers |
| 04/06/2000 | CA2343934A1 Short peptides which selectively modulate the activity of protein kinases |
| 04/06/2000 | CA2343927A1 Artemin, a novel neurotrophic factor |
| 04/06/2000 | CA2343716A1 Contortrostatin (cn) and methods for its use in preventing metastasis and other conditions |
| 04/06/2000 | CA2343696A1 Membrane-associated organizational proteins |
| 04/06/2000 | CA2343656A1 Trex, a novel gene of traf-interacting ext gene family and diagnostic and therapeutic uses thereof |
| 04/06/2000 | CA2343098A1 Combination of bisphosphonate and tetracycline |
| 04/06/2000 | CA2342981A1 Chemotherapy of cancer with acetyldinaline in combination with gemcitabine, capecitabine or cisplatin |
| 04/06/2000 | CA2342622A1 New substituted indolinones,their preparation and their use as medicaments |
| 04/06/2000 | CA2341763A1 Antigenic peptides of aglyco 10b and antibodies thereto |
| 04/06/2000 | CA2341489A1 Somatostatin receptor radioligand with increased uptake |
| 04/06/2000 | CA2340454A1 Benzamide derivatives and their use as cytokine derivatives |
| 04/06/2000 | CA2310804A1 Novel dkr polypeptides |
| 04/05/2000 | EP0990442A1 Therapeutic treatment for chronic myeloid leukemia and active lymphoid leukemia |
| 04/05/2000 | EP0990439A1 Bisaryl compounds and cancer remedies containing the same |
| 04/05/2000 | EP0990038A1 New human lysophospholipase |
| 04/05/2000 | EP0990037A2 Human catalytic telomerase sub-unit and its diagnostic and therapeutic use |
| 04/05/2000 | EP0990031A2 Tumor necrosis factor receptor 5 |
| 04/05/2000 | EP0989999A1 Antitumoral composition based on immunogenic polypeptide with modified cell location |
| 04/05/2000 | EP0989989A1 13-dihydro-3'aziridino anthracyclines |
| 04/05/2000 | EP0989987A1 Spiro-azacyclic derivatives and their use as therapeutic agents |
| 04/05/2000 | EP0989985A1 Fused polycyclic 2-aminopyrimidine derivatives as protein kinase inhibitors |
| 04/05/2000 | EP0989984A1 Bispyrido-cycloheptane compounds useful for inhibition of farnesyl protein transferase |
| 04/05/2000 | EP0989983A1 Benzpyrido cycloheptane compounds useful for inhibition of farnesyl protein transferase |
| 04/05/2000 | EP0989982A1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 04/05/2000 | EP0989981A1 Novel phenyl-substituted tricyclic inhibitors of farnesyl-protein transferase |
| 04/05/2000 | EP0989980A1 Novel tricyclic sulfonamide inhibitors of farnesyl-protein transferase |
| 04/05/2000 | EP0989979A1 Novel n-substituted urea inhibitors of farnesyl-protein transferase |
| 04/05/2000 | EP0989978A1 Tricyclic keto amide derivatives useful as farnesyl protein transferase inhibitors |
| 04/05/2000 | EP0989977A1 Carboxy piperidylacetamide tricyclic compounds useful for inhibition of g-protein function and for treatment of proliferative diseases (farnesyl protein transferase inhibitors) |
| 04/05/2000 | EP0989975A1 Oxazole compounds useful as pge2 agonists and antagonists |
| 04/05/2000 | EP0989973A1 Chalcones having antiproliferative activity |
| 04/05/2000 | EP0989864A1 Pharmaceutical compositions containing antibody-enzyme conjugates in combination with prodrugs |
| 04/05/2000 | EP0989861A1 Immunogenic compositions for induction of anti-tumor immunity |
| 04/05/2000 | EP0989849A2 Therapeutic nanospheres |
| 04/05/2000 | EP0989847A1 Anti-tumoral therapy agent |
| 04/05/2000 | EP0777740B1 Genetic therapy of diseases of the central nervous system with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0777739B1 Genetic therapy of vascular diseases with a cell-specific active substance which is dependent on the cell cycle |
| 04/05/2000 | EP0766664B1 Metalloproteinase inhibitors |
| 04/05/2000 | EP0733072B1 Antibody against carcinoembryonic antigen (cea) |
| 04/05/2000 | EP0595873B1 Cytosine deaminase negative selection system for gene transfer techniques and therapies |
| 04/05/2000 | CN1249780A CASH (caspase homologue) with death effector domain, modulators of function of FAS receptors |
| 04/05/2000 | CN1249753A Farnesyl transferase inhibiting 1,8-annelated quinolinone derivs. substd. with N- or C-linked imidazoles |
| 04/05/2000 | CN1249745A Vitronectin receptor antagonists |
| 04/05/2000 | CN1249743A Arylsulfonylamino hydroxamic acid derivs |
| 04/05/2000 | CN1249691A Immobilized activity stabilized LHRH-antagonist complexes, method for production thereof |
| 04/05/2000 | CN1249188A Medicine for treating leukemia and its preparing process |
| 04/05/2000 | CN1249187A Medicine for treating leukemia and its preparing process |
| 04/05/2000 | CN1051110C Method and related reagent box for sieve examination of leukemia and its tissue |
| 04/05/2000 | CN1051090C Ganglioside GM3 analog having sialic acid residue fluorinated at 9-position |
| 04/05/2000 | CN1051083C Novel substd. puriny derivs. with immunomodulating activity |
| 04/05/2000 | CN1051082C Baccatine III derivs. and their preparation method |
| 04/05/2000 | CN1051074C Use of isoxazole-4-carboxamides and hydroxyalkylidenecyanoacetamides for preparing medicine |
| 04/05/2000 | CN1051015C Anticancer health-care tea |
| 04/04/2000 | US6046341 An active drug having affinity for vasopressin and/or oxytocin receptors |
| 04/04/2000 | US6046314 Spα: a novel scavenger receptor cysteine-rich domain-containing polypeptide, and monoclonal antibodies thereto |
| 04/04/2000 | US6046307 Modulation of mammalian telomerase by peptide nucleic acids |
| 04/04/2000 | US6046237 Non-β-oxidizable fatty acid analogues, their uses as therapeutic active medicaments |
| 04/04/2000 | US6046234 Formulations and methods of reducing toxicity of antineoplastic agents |
| 04/04/2000 | US6046220 Propynyl or dienyl biaromatic compounds |
| 04/04/2000 | US6046211 Amidino derivatives useful as nitric oxide synthase inhibitors |
| 04/04/2000 | US6046195 Useful in the treatment or prevention of pain, inflammation, migraine, emesis and postherpetic neuralgia |
| 04/04/2000 | US6046186 Estrone sulfamate inhibitors of estrone sulfatase, and associated pharmaceutical compositions and methods of use |
| 04/04/2000 | US6046180 NAALADase inhibitors |
| 04/04/2000 | US6046162 Suppression of cell proliferation by decorin |
| 04/04/2000 | US6046159 Formulations and methods of reducing toxicity of antineoplastic agents |
| 04/04/2000 | US6046044 Cisplatin resistance proteins |
| 04/04/2000 | US6045997 Materials and methods relating to the identification and sequencing of the BRCA2 cancer susceptibility gene and uses thereof |
| 04/04/2000 | US6045831 Nuclear inhibitor I-92 and its use for the production of a medicament |
| 04/04/2000 | US6045826 Antioxidant/antiaging medicinal or cosmetic mixture for skin disorder prophylaxis |
| 04/04/2000 | US6045808 Method for removing high boiling solvents from drug formulations by vacuum drying |